peptilab semaglutide (GLP-1) Research Peptide PDB-101: Diabetes Mellitus: Diabetes Mellitus:

1/9 BREAKING: The first Phase 3 trial for Retatrutide in Type 2 Diabetes (TRANSCEND-T2D-1) is out, and the results are incredibly promising

For patients whose hunger doesn't resolve with dosing and lifestyle optimization, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month of treatment) to identify whether your appetitive resistance stems from genetic variants in GLP1R, GIPR, FTO, MC4R, or upstream metabolic pathways

Heart Health: Clinical studies have shown that Semaglutide can reduce the risk of major cardiovascular events, such as heart attacks and strokes, in individuals with type 2 diabetes

Stay Hydrated Hydration plays a crucial role in maintaining smooth digestion